Company ProfilePremium

NUVASIVE, INC.

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
NUVASIVE, INC. - Healthcare showcase

Year Founded & Workforce

1997

2,400 Employees

Industry

Healthcare

Services

Thoracolumbar Posterior Fixation
N

NUVASIVE, INC. Employee Contacts

113 verified contactsNames, job titles, seniority and locations

View Employee Contacts

NUVASIVE, INC. Overview

Company Headquarters: California, US

Founded: 1997

Workforce: ~: 2,400+

Company Working: NuVasive, Inc. (NuVasive) is a leading medical device company in the global spine surgery market, focused on developing minimally disruptive surgical products and procedurally integrated solutions for spine surgery. The company’s currently marketed product portfolio is focused on applications for spine fusion surgery, including ancillary products and services used to aid in the surgical procedure. The company’s procedurally integrated solutions use innovative, technological advancements, and a minimally disruptive surgical platform called Maximum Access Surgery (MAS), to provide surgical efficiency, operative reliability, and procedural versatility. Its international headquarter is located in Amsterdam, Netherlands.

Strategy

NuVasive focuses on establishing its maximum access surgery (MAS) platform as the standard of care. It also focuses to develop and introduce procedurally-integrated solutions and new innovative products. Additionally, the expansion of product portfolio and improving operational activities are the focus areas of the company’s business strategies.

Company Snapshot

$962M

Revenue

2,400

Employees

1997

Founded

California, US

Headquarters

SWOT Analysis

Strengths

  • Strong product portfolio
  • Worldwide presence

Weaknesses

  • Manufacturing facilities limited to the US

Opportunities

  • Expansion in untapped regions

Threats

  • Regulatory policies
  • High competition from existing market giants

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
September 2018Product ExpansionNuVasive expanded the spinal interbody portfolio with the launch of the TLX 20 Degree implant. This product expansion would help the company to build a comprehensive expandable portfolio to support optimal clinical outcomes.

Product Offering

  • NUVASIVE, INC.
    • Thoracolumbar Posterior Fixation

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 962 Mn in 2016 to USD 1,102 Mn in 2018.
NUVASIVE, INC. — By Business Segment
Series (USD Mn)201620172018
Sales9621,0271,102

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.